Table 2 This table summarizes patient demographics and clinical characteristics from the original center and external validation groups, including gender, age distribution, disease type, and treatments received.
Category | Original center patients count | External validation patients count | |
|---|---|---|---|
Gender Distribution | Female | 75 | 7 |
Male | 28 | 3 | |
Age distribution | Number of patients | 103 | 10 |
Mean Age | 33.07 years | 33.7 years | |
Standard deviation | 10.61 | 11.1 | |
Minimum age | 16 years | 18 years | |
Maximum age | 64 years | 60 years | |
25th percentile | 24 | 29 | |
50th percentile | 33 | 33 | |
75th percentile | 42 | 44 | |
Disease type | Relapsing–remitting (RR) | 68 | 7 |
Secondary progressive (SP) | 4 | 1 | |
Primary progressive (PP) | 1 | 1 | |
Missing data | 30 | 1 | |
Treatments | Dimethyl fumarate (DMF) | 4 | 2 |
Glatiramer acetate (GA) | 6 | 0 | |
Rituximab (RTX) | 5 | 6 | |
Interferon beta-1a (AVONEX) | 3 | 0 | |
Other Treatments (each) | 51 | 0 | |
Missing Data | 34 | 2 |